Dysis ii acs china研究
WebMethods: The Dyslipidemia International Study (DYSIS) II was a multinational, observational study that enrolled patients over 18 years of age who were hospitalised with an ACS in 2013-2014 and survived until discharge. Patients were analysed according to whether or not they were treated with LLT prior to hospital admission. http://www.hyxcchina.com/news/984.html
Dysis ii acs china研究
Did you know?
http://health.china.com.cn/2013-11/06/content_6435363.htm WebOct 15, 2024 · The results from this real-world DYSIS II study in post-ACS patients from China suggest that less than one-fifth (17.1%) of patients were at LDL-C goal of <1.8 mmol/L (per 2016 Chinese Adult Lipid ...
WebAim: To document the prevalence of lipid abnormalities and the achievement of lipid targets among patients surviving an ACS and in patients with stable coronary heart disease (CHD), using data from the DYSIS II study. Methods: DYSIS II was an observational cross-sectional study conducted in 21 countries (2012-2014). We report data from the ... WebAug 1, 2014 · This study, the Dyslipidemia International Study of China (DYSIS-China), has as its objective to estimate the prevalence of persistent dyslipidaemia in patients treated …
Webcurrent ACS) or a secondary prevention program (3.7% of ACS and 11.7% of stable CHD patients) was infrequent. ... DYSIS II was a multinational observational study in adults with established CHD ... WebAug 1, 2014 · To investigate lipid abnormalities in patients with and without type 2 diabetes hospitalised for an ACS, and use of LLT before admission and 4 months after the event. Patients were included in the observational DYSIS II study if they were hospitalised for an ACS and had a full lipid profile. Of 3803 patients, diabetes was documented in 1344 (54 ...
WebSep 21, 2024 · The mean LDL-C levels were 86.9 mg/dL and 103.2 mg/dL in the CHD and the ACS cohorts, respectively. Despite a majority of the patients having received lipid-lowering medications (91.7 percent and 63.4 percent, respectively), only 31 percent of the CHD cohort and 23 percent of the ACS cohort had achieved the guideline-recommended …
WebNov 16, 2024 · A large observational study (DYSIS-China) showed that although the majority (88.9%) of dyslipidemia patients in China were treated with statins, the overall … sleep specialist frederick mdWebwith ACS in China. We report on patterns of LLT, and LDL-C goal attainment at baseline (ACS) and at 6 months post-ACS in China. 2 METHODS DYSIS II-China was a multicenter prospective observational study conducted between September 2024 and May 2024 at 28 cardiology departments of tertiary hospitals. The study protocol was approved sleep specialist in colorado springsWebNov 26, 2012 · Yan X, Li Y, Dong Y, Wu Y, Li J, Bian R, Hu D. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia … sleep specialist chattanooga tnWebwith ACS in China. We report on patterns of LLT, and LDL-C goal attainment at baseline (ACS) and at 6 months post-ACS in China. 2 METHODS DYSIS II-China was a … sleep specialist for childrenWebMar 1, 2024 · Methods: The Dyslipidemia International Study (DYSIS) II was a multinational, observational study that enrolled patients over 18 years of age who were hospitalised with an ACS in 2013-2014 and ... sleep specialist fort worthsleep specialist in chicagoWebZillow has 179 homes for sale in Ashburn VA. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. sleep specialist in idaho falls id